Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional, Observational Study on Retreatment of Chronic Hepatitis C Patients Previous Treatment Failure, Using Peginterferon Alfa-2a and Ribavirin Based Regimens

NCT01798576 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01798576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01798576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional, Observational Study on Retreatment of Chronic Hepatitis C Patients Previous Treatment Failure, Using Peginterferon Alfa-2a and Ribavirin Based Regimens
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Terminated
Start date
November 30, 2012
Completion date
June 30, 2015
Enrollment
282 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic